当前位置：首页 > 文献互助 > 互助详情

Chronic kidney disease复制

用户qF7pME5zq23w 1个月前 134 10 已完结

1. 系统已在2026-08-13 16:00:29对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

WG Herrington, PK Judge, ME Grams, C Wanner
The Lancet, 2026
thelancet.com
Globally, the prevalence of chronic kidney disease is estimated to be approximately 850
million cases, with approximately 4 million individuals needing kidney replacement therapy for …

上一篇：Homemade open-source full-Stokes polarimeter based on division of amplitude

下一篇：Differential opioid tolerance and opioid-induced hyperalgesia: a clinical reality

互助时间线

2026-08-06 16:03:03 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2026-08-06 16:00:29 [上传文件]

jodie0105上传了文件(pdf 1.77 MB), 求助状态变成 待确认

2026-08-06 15:53:08 [发起求助]

最新发布的求助

Crystallization of Organic Compounds: An Industrial Perspective 4分钟前
卓國雄、盧俊宏（2005）。中文版表現失敗評估量表之修訂研究：探索性和驗證性因素分析。大專體育學刊，7(2)，111-123。 10小时前
Extending the Treatment Window for Intravenous Thrombolysis in Acute Ischemic Stroke 10小时前
Multiomics Integration Identifies a Molecular Subtype of Intrahepatic Cholangiocarcinoma With Enhanced Benefit From Adjuvant Therapy 11小时前
Multiomics Integration Identifies a Molecular Subtype of Intrahepatic Cholangiocarcinoma With Enhanced Benefit From Adjuvant Therapy 11小时前
Integrative multi-omics identifies cholangiolocarcinoma as a distinct molecular subtype of intrahepatic cholangiocarcinoma 11小时前
Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns 11小时前
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study 11小时前
Tegileridine vs . sufentanil for postoperative analgesia in general surgery: A prospective, randomized, controlled, non‐inferiority trial. 11小时前
Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for 90 Y Radioembolization with Immunotherapy in HCC 11小时前
Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti‐PD‐1 immunotherapy for unresectable intrahepatic cholangiocarcinoma 11小时前
Hepatic Artery Infusion Chemotherapy as a First‐Line Treatment in Unresectable Cholangiocarcinoma: A Systematic Review and Meta‐Analysis 11小时前

wispass工作室 Copyright © 蜀ICP备20005939号-4 www.wispass.com